<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-18876" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Cardiac Abscess</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ramos Tuarez</surname>
            <given-names>Fergie J.</given-names>
          </name>
          <aff>University of Miami</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yelamanchili</surname>
            <given-names>Varun S.</given-names>
          </name>
          <aff>Mclaren Hospital System</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Sanjeev</given-names>
          </name>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Law</surname>
            <given-names>Mark A.</given-names>
          </name>
          <aff>Childrens of AL, Un of AL at Birmingham</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Fergie Ramos Tuarez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Varun Yelamanchili declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sanjeev Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Mark Law declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>6</day>
          <month>10</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-18876.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>A cardiac abscess is a suppurative infection affecting the myocardium, endocardium, and native or prosthetic valve tissue. This condition typically develops due to bacteremia, sepsis, or as an extension of infective endocarditis, with <italic toggle="yes">Staphylococcus aureus</italic> and <italic toggle="yes">Escherichia coli</italic> being the most common causative organisms. Cardiac abscesses can form in areas of the heart previously damaged by myocardial infarction or near cardiac valves, particularly the aortic valve, which is most susceptible. Complications of cardiac abscess include conduction abnormalities, especially atrioventricular block, and increased risk of embolization, morbidity, and mortality.</p>
        <p>Perivalvular abscesses are often seen in patients with prosthetic valves or severe infective endocarditis and can disrupt the cardiac electrical system or compress coronary arteries. Diagnosis involves blood cultures, echocardiography, and various imaging studies, which are particularly sensitive. Immediate treatment includes broad-spectrum antibiotics and often surgical intervention. Close monitoring and follow-up are essential to ensure resolution and prevent complications.&#x000a0;This activity for healthcare professionals reviews the epidemiology, etiology, and clinical signs and symptoms of cardiac abscesses, facilitating recognition of the disease process, performing the recommended evaluation, and implementing an appropriate interprofessional management approach to improve patient outcomes.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Apply the pathophysiologic mechanisms of cardiac abscess development to the common clinical presentation of the disease.</p></list-item><list-item><p>Identify patients at risk for cardiac abscess development based on their clinical history and presentation.</p></list-item><list-item><p>Implement the appropriate treatment in a patient with a cardiac abscess.</p></list-item><list-item><p>Communicate&#x000a0;the importance of improving care coordination among interprofessional team members to improve outcomes for patients affected by cardiac abscesses.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18876&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18876">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-18876.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>A cardiac abscess is a suppurative infection of the myocardium, endocardium, and native or prosthetic valve tissue. Like other abscesses,&#x000a0;it develops either by dissemination from a distant source such as bacteremia or sepsis or by direct extension of a preexisting cardiac infective focus. Infective endocarditis has long been identified as the main cause of the latter. Although the incidence of cardiac abscesses continues to be investigated, it is presumably higher than noted postmortem&#x000a0;and is of great importance when deciding the prognosis of and therapeutic strategy for patients. Cardiac abscesses are typically monomicrobial; the most common etiologic agents are&#x000a0;<italic toggle="yes">Staphylococcus aureus</italic> or <italic toggle="yes">Escherichia coli</italic>. Polymicrobial cardiac abscesses are less typical but do occur<italic toggle="yes">.</italic><xref ref-type="bibr" rid="article-18876.r1">[1]</xref><xref ref-type="bibr" rid="article-18876.r2">[2]</xref><xref ref-type="bibr" rid="article-18876.r3">[3]</xref>&#x000a0;Myocardial abscesses may also form in regions of the heart that have experienced prior damage, such as those affected by recent infarction.<xref ref-type="bibr" rid="article-18876.r4">[4]</xref></p>
        <p>Significant complications of a cardiac abscess, whether alone or with valve tissue, are conduction abnormalities. The incidence of perivalvular abscess among patients with infective endocarditis&#x000a0;is between 30% and 40%, with the aortic valve having a higher predisposition than the mitral valve and annulus. Native aortic valve endocarditis, usually located&#x000a0;in a weak part of the annulus near the atrioventricular node (AV), clearly demonstrates the anatomic predisposition and exemplifies why abscesses and heart block present as frequent sequelae.</p>
        <p>Perivalvular abscesses are also more familiar with prosthetic valves. In this case, the annulus, instead of the leaflet, is usually the primary site of infection. The degree of conduction disruption, therefore, depends on the extent of the involvement of the conduction system and is more commonly seen in perivalvular aortic abscesses. Additionally, the severe extension of perivalvular infection can also result in extrinsic coronary arterial compression or disruption, leading to acute coronary syndrome.&#x000a0;Thus far, only aortic valve involvement and current intravenous drug use (IVDU) have been prospectively identified as independent risk factors for a perivalvular abscess. Any patient with a cardiac abscess, regardless of all other factors, has an increased risk of embolization, morbidity, and mortality.<xref ref-type="bibr" rid="article-18876.r5">[5]</xref>&#x000a0;Right-sided infective endocarditis represents 5% to 10% of all cases and is frequently linked to IVDU, intracardiac devices, and central venous catheters. The prevalence of these factors has increased in the United States over the last 2 decades.<xref ref-type="bibr" rid="article-18876.r6">[6]</xref></p>
      </sec>
      <sec id="article-18876.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>Cardiac abscesses are most commonly thought to occur primarily via extension of a preexisting cardiac infection, as in the case of infective endocarditis. Secondary causes of cardiac abscess are believed to be due to bacteremia (persistent or transient) without a known cardiac source, susceptible heart tissue soon after myocardial infarction (MI), or prosthetic valve disease, usually in the setting of bacteremia. Other less common predisposing factors may be trauma, penetrating wounds, deep burns, infected transplanted hearts, infected sternal incision sites, pseudoaneurysm, HIV, or parasitic infections.<xref ref-type="bibr" rid="article-18876.r7">[7]</xref></p>
      </sec>
      <sec id="article-18876.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>Cardiac abscesses are rare in the United States. S<italic toggle="yes">taphylococcus aureus</italic> is the most common pathogen when the disease is present. The mitral valve is most commonly implicated in patients with native valves and heart tissue. A 2009 study by Murdoch et al looked at the presentation and etiology and estimated the patient incidence of infective endocarditis at approximately 15%. Regarding prosthetic tissue or valves, the infection tends to be entirely periannular, extends to the myocardium, and results in paravalvular abscesses from the dehiscence of the valve.<xref ref-type="bibr" rid="article-18876.r8">[8]</xref><xref ref-type="bibr" rid="article-18876.r9">[9]</xref></p>
        <p>The following are organisms noted to be involved in cardiac abscess formation:</p>
        <list list-type="bullet">
          <list-item>
            <p>
<italic toggle="yes">Staphylococcus aureus</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Haemophilus species</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Enterococci&#x000a0;</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Escherichia coli</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">&#x000df;-hemolytic streptococci&#x000a0;</italic>
</p>
          </list-item>
          <list-item>
            <p>
<italic toggle="yes">Streptococcus&#x000a0;</italic>
<italic toggle="yes">pneumoniae&#x000a0;</italic>
</p>
          </list-item>
          <list-item>
            <p><italic toggle="yes">Bacteroides</italic> species</p>
          </list-item>
          <list-item>
            <p>Parasitic organisms</p>
          </list-item>
          <list-item>
            <p>Hydatid cysts</p>
          </list-item>
          <list-item>
            <p>Miscellaneous</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18876.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Current or prior infective endocarditis is the primary predisposing factor for a cardiac abscess. The most common sites involved are the aortic valve, the ventricular septa, the mitral valves, and the papillary muscles. <italic toggle="yes">S aureus</italic>, the most commonly involved causative agent, is present in up to one-third of all&#x000a0;cases and has an even higher incidence in patients with prosthetic valves.</p>
        <p>Secondly, bacteremia may become a significant pathophysiologic mechanism, although abscesses due to bacteremia alone tend not to be large enough to cause death. Most studies report this as an incidental postmortem finding. Moreover, the site of prior MI has also been documented as a&#x000a0;predisposing&#x000a0;risk factor for the development of a cardiac abscess in patients in whom bacteremia is of concern. Such a scenario is plausible in a patient with a known prior infection undergoing an acute coronary syndrome or acquiring the infection soon following an MI. Necrosis of muscle fibers post-MI, in addition to an inflammatory state and decreased perfusion with lack of blood flow, is also suspected to increase myocardium susceptibility to this complication.<xref ref-type="bibr" rid="article-18876.r10">[10]</xref></p>
      </sec>
      <sec id="article-18876.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Depending on the acuity of presentation (ie, acute versus subacute infective endocarditis), the location of the cardiac abscess, and the overall state of a patient with bacteremia, several clinical features may be observed during clinical assessment.</p>
        <p>
<bold>Clinical History</bold>
</p>
        <p>Highly variable, vague symptoms are common. An acute presentation is more toxic, whereas a subacute patient presents more indolently. Depending on the conduction abnormality, symptoms of any degree of heart block may be present. Other symptoms may include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever, subjective or objective</p>
          </list-item>
          <list-item>
            <p>Anorexia</p>
          </list-item>
          <list-item>
            <p>Myalgias</p>
          </list-item>
          <list-item>
            <p>Headache</p>
          </list-item>
          <list-item>
            <p>Dyspnea</p>
          </list-item>
          <list-item>
            <p>Joint pain</p>
          </list-item>
          <list-item>
            <p>Rashes</p>
          </list-item>
          <list-item>
            <p>Cough</p>
          </list-item>
          <list-item>
            <p>Chest pain</p>
          </list-item>
        </list>
        <p>
<bold>Physical Examination</bold>
</p>
        <p>Findings associated with cardiac abscesses frequently manifest due to infective endocarditis or cardiac abscess complications that develop. Clinicians must remember that the absence of these findings does not exclude infective endocarditis, as clinical features are not sufficiently sensitive or specific for this disease process. Findings that can be indicative of cardiac abscess include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever</p>
          </list-item>
          <list-item>
            <p>Signs and symptoms of heart failure (eg, S3 heart sounds, jugular venous distention, and pulmonary crackles)</p>
          </list-item>
          <list-item>
            <p>Signs and symptoms of valvular insufficiency (usually systolic murmurs related to the tricuspid, mitral, or aortic valves or diastolic murmurs, more common in patients with prosthetic valve endocarditis and perivalvular leak or disease)</p>
          </list-item>
          <list-item>
            <p>Focal neurologic complaints due to emboli</p>
          </list-item>
          <list-item>
            <p>Back pain associated with osteomyelitis</p>
          </list-item>
          <list-item>
            <p>Petechiae, nonspecific</p>
          </list-item>
          <list-item>
            <p>Subungal or splinter hemorrhages</p>
          </list-item>
          <list-item>
            <p>Osler nodes (painful subcutaneous nodules most commonly on hands)</p>
          </list-item>
          <list-item>
            <p>Janeway lesions (nontender lesions of palms or soles)</p>
          </list-item>
          <list-item>
            <p>Roth spots (retinal hemorrhages visible during fundoscopy)</p>
          </list-item>
          <list-item>
            <p>Splenomegaly</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18876.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>All patients with a suspected cardiac abscess require an electrocardiogram (ECG).&#x000a0;Continuous electrocardiographic monitoring is preferred; a new atrioventricular block has a positive predictive value of 88% for abscess formation but a low sensitivity of 45%.</p>
        <p>
<bold>Laboratory Studies</bold>
</p>
        <p>Various laboratory tests are recommended when evaluating a patient with a suspected cardiac abscess, including blood and urine studies and blood cultures. These studies help evaluate the differential diagnoses that should be considered based on the clinical features present. A cardiac abscess in the setting of negative blood cultures is possible. For example, a patient whose initial evaluation demonstrated bacteremia with&#x000a0;no physical signs of infective endocarditis or cardiac conduction deficit&#x000a0;may receive intravenous (IV) antibiotics before&#x000a0;a further workup. Therefore, cultures may not be reliable. Additionally, if cultures are not drawn&#x000a0;correctly, the likelihood&#x000a0;of positive results decreases significantly.</p>
        <p>
<bold>Imaging Studies</bold>
</p>
        <p>Echocardiography is an important component of the evaluation of a patient with a suspected cardiac abscess. Transesophageal echocardiography (TEE) is the recommended imaging study in the initial assessment of a patient with a suspected cardiac abscess. If TEE is unavailable, transthoracic echocardiography (TTE) should be performed. TEE is more sensitive and specific for cardiac abscess than TTE.</p>
        <p>Electrocardiogram-gated cardiac computed tomography (CT) offers multiplanar cine reconstructions that complement the information obtained from echocardiography. While TEE is more sensitive for detecting small vegetation (&#x0003c;4 mm), CT is superior in assessing the anatomical extent of the disease. Additionally, cardiac CT is useful for preoperative assessment of the risks associated with sternal reentry. When evaluating coronary anatomy, CT may be favored over invasive angiography to reduce the potential risk of infectious embolization into the coronary arteries.<xref ref-type="bibr" rid="article-18876.r11">[11]</xref></p>
        <p>The role of cardiac magnetic resonance imaging (MRI) in diagnosing suspected infective endocarditis remains undefined, with image quality often impacted by artifacts from prosthetic materials. However, cardiac MRI excels in tissue characterization, detecting myocardial inflammation or fibrosis using T2-weighted sequences and post-gadolinium delayed enhancement sequences. Long inversion time imaging (around 600 ms) can distinguish vegetations from other intracardiac masses like thrombi. Additionally, MRI with gadolinium-based contrast is considered a safer alternative in patients with renal impairment, where iodine-based contrast for CT might pose a risk.<xref ref-type="bibr" rid="article-18876.r12">[12]</xref></p>
        <p>Positron emission tomography CT (PET-CT) is widely recognized for its effectiveness in assessing prosthetic valve endocarditis and infections of vascular grafts. Research has demonstrated increased sensitivity in detecting endocarditis, though this may come with a reduction in specificity. A significant limitation of PET-CT is its difficulty in distinguishing endocarditis from other inflammatory processes, particularly in patients recovering from recent cardiac surgery where tissue healing may be ongoing.<xref ref-type="bibr" rid="article-18876.r11">[11]</xref><xref ref-type="bibr" rid="article-18876.r13">[13]</xref></p>
      </sec>
      <sec id="article-18876.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>Intravenous antibiotics should be administered promptly once infective endocarditis or a cardiac abscess is suspected. Empiric broad-spectrum antibiotics, until further characterization of infective species, should be monitored for at least 6 weeks of therapy in this patient population.<xref ref-type="bibr" rid="article-18876.r14">[14]</xref></p>
        <p>When approaching a patient with a cardiac abscess, the surgery consult and the time of surgical intervention are of high importance. Patients in whom surgery is delayed experience increased morbidity and mortality. Thus, early surgery is recommended. Surgery for these patients aims to eradicate the infection and correct hemodynamic abnormalities.</p>
        <p>However, some patients with periannular extension of infection or myocardial abscess could potentially be treated without surgical intervention. These patients include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patients with smaller (&#x0003c;1 cm) abscesses</p>
          </list-item>
          <list-item>
            <p>Patients who do not have complications of heart block, an echocardiographic progression of abscess during antibiotic therapy</p>
          </list-item>
          <list-item>
            <p>Patients who do not have valvular dehiscence or insufficiency</p>
          </list-item>
        </list>
        <p>According to the recent Endocarditis European Society of Cardiology&#x000a0;(ESC) Guidelines and data from the European Endocarditis (EURO-ENDO) registry, 11.5% of patients presented with conduction disturbances at diagnosis, primarily 1st-, 2nd-, and 3rd-degree atrioventricular block (AVB). The development of a new AVB due to an abscess indicates urgent cardiac surgery.<xref ref-type="bibr" rid="article-18876.r15">[15]</xref>&#x000a0;These recommended that patients who do not undergo surgery are monitored closely with serial TEE repeated at 2, 4, and 8 weeks after completion of antibiotic therapy.&#x000a0;</p>
      </sec>
      <sec id="article-18876.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Differential diagnoses of cardiac abscess that should be considered during evaluation include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Fever of unknown origin (FUO)</p>
          </list-item>
          <list-item>
            <p>First-degree atrioventricular block</p>
          </list-item>
          <list-item>
            <p>Heart transplantation</p>
          </list-item>
          <list-item>
            <p>Heart-lung transplantation</p>
          </list-item>
          <list-item>
            <p>Infections after solid organ transplantations</p>
          </list-item>
          <list-item>
            <p>Infective endocarditis</p>
          </list-item>
          <list-item>
            <p>Mitral regurgitation</p>
          </list-item>
          <list-item>
            <p>Myocardial infarction</p>
          </list-item>
          <list-item>
            <p>Penetrating chest trauma</p>
          </list-item>
          <list-item>
            <p>Septic shock</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18876.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>Patients can recover quickly if the diagnosis is made early and treatment ensues without delay. Without surgical intervention, the prognosis is usually not favorable.</p>
      </sec>
      <sec id="article-18876.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Complications of cardiac abscess include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Heart block</p>
          </list-item>
          <list-item>
            <p>Arrhythmias</p>
          </list-item>
          <list-item>
            <p>Congestive heart failure</p>
          </list-item>
          <list-item>
            <p>Stroke</p>
          </list-item>
          <list-item>
            <p>Multiple organ failure</p>
          </list-item>
          <list-item>
            <p>Acute respiratory distress syndrome</p>
          </list-item>
          <list-item>
            <p>Death</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18876.s12" sec-type="Postoperative and Rehabilitation Care">
        <title>Postoperative and Rehabilitation Care</title>
        <p>Posttreatment and postsurgical considerations of cardiac abscess management include:</p>
        <list list-type="bullet">
          <list-item>
            <p>These patients often require&#x000a0;6 to 8 weeks of parenteral antibiotic therapy. They also need deep vein thrombosis (DVT) prophylaxis. Those with a prosthetic valve may require oral anticoagulants.</p>
          </list-item>
          <list-item>
            <p>Because the patients are critically ill, nutrition is essential.</p>
          </list-item>
          <list-item>
            <p>An exercise program is also recommended to help prevent muscle atrophy and DVT.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18876.s13" sec-type="Consultations">
        <title>Consultations</title>
        <p>The management of a cardiac abscess may require input from different specialties, including:</p>
        <list list-type="bullet">
          <list-item>
            <p>Cardiologist</p>
          </list-item>
          <list-item>
            <p>Cardiac surgeon</p>
          </list-item>
          <list-item>
            <p>Physical therapy</p>
          </list-item>
          <list-item>
            <p>Dietitian</p>
          </list-item>
          <list-item>
            <p>Intensivist</p>
          </list-item>
          <list-item>
            <p>Infectious disease</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-18876.s14" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patient education regarding their illness and emphasis on the significance of prophylaxis is crucial.&#x000a0;Prophylaxis remains a longstanding subject in the prevention of infective endocarditis or cardiac abscess. Thus far, prophylaxis is mainly based on observational studies. Places such as the United Kingdom no longer endorse&#x000a0;antibiotic prophylaxis for dental procedures to prevent infective endocarditis, the leading source of cardiac abscesses.</p>
        <p>One argument against prophylaxis is that tooth brushing has been proven to cause bacteremia. This makes it challenging to assess rare versus high-magnitude transient bacteremia and its effect on infective endocarditis and its sequelae. For this reason, the United States and European countries have agreed that prophylaxis is reserved only for those at the highest risk.</p>
        <p>On the same matter, the widespread use of antibiotics to prevent and treat infective endocarditis and abscesses could potentially increase the incidence of polymicrobial infection and antibiotic resistance, especially in immunocompromised patients.&#x000a0;Furthermore, the risk of drug-related adverse effects increases with prolonged drug exposure. In the case of antibiotic therapy, vestibular, auditory, and nephrotoxic adverse effects are of significant concern. These adverse effects require close monitoring and an expert team to manage infective endocarditis and its complications; unfortunately, these are not widely available.</p>
      </sec>
      <sec id="article-18876.s15" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Effective management of myocardial abscesses requires coordinated efforts from an interprofessional team to enhance patient-centered care, improve outcomes, and ensure patient safety. Physicians, including cardiologists, cardiovascular surgeons, and infectious disease specialists, must work together to monitor for complications, initiate appropriate antibiotics, and consider surgical interventions when necessary. Advanced practitioners and intensive care specialists oversee the acute management of critically ill patients, monitoring for organ failure and maintaining hemodynamic stability. Nurses play a pivotal role in patient education, infection prevention, and ongoing monitoring of vitals, while pharmacists ensure proper antibiotic dosing, anticoagulation management, and drug safety. Nephrologists and dietitians address comorbidities like renal failure and nutritional needs, while physical therapists promote mobility and prevent complications like deep vein thrombosis.</p>
        <p>Effective interprofessional communication and collaboration are essential for timely diagnosis, early intervention, and a structured, aggressive approach to care, which are vital in reducing the high morbidity and mortality associated with myocardial abscesses. This coordinated strategy ensures that each health professional contributes their expertise to optimize both team performance and patient outcomes.</p>
      </sec>
      <sec id="article-18876.s16">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=18876&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=18876">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/heart-health/cardiac-abscess-heart-infection/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=18876">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/18876/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=18876">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-18876.s17">
        <title>References</title>
        <ref id="article-18876.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Grant</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Page</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Iyer</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Contained myocardial abscess following a myocardial infarction.</article-title>
            <source>J Card Surg</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>33</volume>
            <issue>3</issue>
            <fpage>144</fpage>
            <page-range>144-145</page-range>
            <pub-id pub-id-type="pmid">29526056</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Desaint</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chauvat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Garaud</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Andremont</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Plantef&#x000e8;ve</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mentec</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Contou</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Perivalvular Mitral Abscess Fistulised to the Pericardial Cavity Revealing Staphylococcal Endocarditis.</article-title>
            <source>Heart Lung Circ</source>
            <year>2018</year>
            <month>Mar</month>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>e34</fpage>
            <page-range>e34-e37</page-range>
            <pub-id pub-id-type="pmid">29133025</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nand</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Singla</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Magu</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Cardiac Abscess with Ventricular Aneurysm Secondary to Old Myocardial Infarction.</article-title>
            <source>J Assoc Physicians India</source>
            <year>2017</year>
            <month>May</month>
            <volume>65</volume>
            <issue>5</issue>
            <fpage>95</fpage>
            <page-range>95-96</page-range>
            <pub-id pub-id-type="pmid">28598059</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rodella</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pegorin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rosati</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Raffo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vizzardi</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Metra</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Intramyocardial abscess and endoventricular thrombosis: a complex case.</article-title>
            <source>Int J Cardiovasc Imaging</source>
            <year>2024</year>
            <month>Jul</month>
            <volume>40</volume>
            <issue>7</issue>
            <fpage>1597</fpage>
            <page-range>1597-1603</page-range>
            <pub-id pub-id-type="pmid">38613607</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kong</surname>
                <given-names>WKF</given-names>
              </name>
              <name>
                <surname>Choong</surname>
                <given-names>CC</given-names>
              </name>
              <name>
                <surname>Sule</surname>
                <given-names>JA</given-names>
              </name>
              <name>
                <surname>Poh</surname>
                <given-names>KK</given-names>
              </name>
              <name>
                <surname>Kofidis</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Paravalvular root abscess with mycotic pseudoaneurysm.</article-title>
            <source>Eur Heart J</source>
            <year>2018</year>
            <month>Nov</month>
            <day>01</day>
            <volume>39</volume>
            <issue>41</issue>
            <fpage>3751</fpage>
            <page-range>3751-3752</page-range>
            <pub-id pub-id-type="pmid">30020432</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Shmueli</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Thomas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Flint</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Setia</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Janjic</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Siegel</surname>
                <given-names>RJ</given-names>
              </name>
            </person-group>
            <article-title>Right-Sided Infective Endocarditis 2020: Challenges and Updates in Diagnosis and Treatment.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2020</year>
            <month>Aug</month>
            <day>04</day>
            <volume>9</volume>
            <issue>15</issue>
            <fpage>e017293</fpage>
            <pub-id pub-id-type="pmid">32700630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Kang</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>YB</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KI</given-names>
              </name>
            </person-group>
            <article-title>Complicated infective endocarditis: a case series.</article-title>
            <source>J Med Case Rep</source>
            <year>2017</year>
            <month>May</month>
            <day>08</day>
            <volume>11</volume>
            <issue>1</issue>
            <fpage>128</fpage>
            <pub-id pub-id-type="pmid">28482860</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Perrotta</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Aljassim</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Jeppsson</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bech-Hanssen</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Svensson</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Survival and quality of life after aortic root replacement with homografts in acute endocarditis.</article-title>
            <source>Ann Thorac Surg</source>
            <year>2010</year>
            <month>Dec</month>
            <volume>90</volume>
            <issue>6</issue>
            <fpage>1862</fpage>
            <page-range>1862-7</page-range>
            <pub-id pub-id-type="pmid">21095327</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Subbaraju</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Morakhia</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Midha</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Kamath</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Saravu</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Clinical - microbiological characterization and risk factors of mortality in infective endocarditis from a tertiary care academic hospital in Southern India.</article-title>
            <source>Indian Heart J</source>
            <year>2018</year>
            <season>Mar-Apr</season>
            <volume>70</volume>
            <issue>2</issue>
            <fpage>259</fpage>
            <page-range>259-265</page-range>
            <pub-id pub-id-type="pmid">29716704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Oliveira</surname>
                <given-names>JLR</given-names>
              </name>
              <name>
                <surname>Santos</surname>
                <given-names>MAD</given-names>
              </name>
              <name>
                <surname>Arnoni</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Ramos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Togna</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Ghorayeb</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Kroll</surname>
                <given-names>RTM</given-names>
              </name>
              <name>
                <surname>Souza</surname>
                <given-names>LCB</given-names>
              </name>
            </person-group>
            <article-title>Mortality Predictors in the Surgical Treatment of Active Infective Endocarditis.</article-title>
            <source>Braz J Cardiovasc Surg</source>
            <year>2018</year>
            <season>Jan-Feb</season>
            <volume>33</volume>
            <issue>1</issue>
            <fpage>32</fpage>
            <page-range>32-39</page-range>
            <pub-id pub-id-type="pmid">29617499</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lo Presti</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Elajami</surname>
                <given-names>TK</given-names>
              </name>
              <name>
                <surname>Zmaili</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Reyaldeen</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Xu</surname>
                <given-names>B</given-names>
              </name>
            </person-group>
            <article-title>Multimodality imaging in the diagnosis and management of prosthetic valve endocarditis: A contemporary narrative review.</article-title>
            <source>World J Cardiol</source>
            <year>2021</year>
            <month>Aug</month>
            <day>26</day>
            <volume>13</volume>
            <issue>8</issue>
            <fpage>254</fpage>
            <page-range>254-270</page-range>
            <pub-id pub-id-type="pmid">34589164</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Woolen</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Shankar</surname>
                <given-names>PR</given-names>
              </name>
              <name>
                <surname>Gagnier</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>MacEachern</surname>
                <given-names>MP</given-names>
              </name>
              <name>
                <surname>Singer</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Davenport</surname>
                <given-names>MS</given-names>
              </name>
            </person-group>
            <article-title>Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent: A Systematic Review and Meta-analysis.</article-title>
            <source>JAMA Intern Med</source>
            <year>2020</year>
            <month>Feb</month>
            <day>01</day>
            <volume>180</volume>
            <issue>2</issue>
            <fpage>223</fpage>
            <page-range>223-230</page-range>
            <pub-id pub-id-type="pmid">31816007</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vinnakota</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tarabochia</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Tan</surname>
                <given-names>NY</given-names>
              </name>
              <name>
                <surname>Miranda</surname>
                <given-names>WR</given-names>
              </name>
              <name>
                <surname>Sinak</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Anavekar</surname>
                <given-names>NS</given-names>
              </name>
              <name>
                <surname>Abu Saleh</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bagameri</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bennett</surname>
                <given-names>CE</given-names>
              </name>
            </person-group>
            <article-title>Multimodal Imaging in <italic>Mycobacterium Chimaera</italic> Cardiovascular Infections: The Mayo Clinic Experience.</article-title>
            <source>Mayo Clin Proc Innov Qual Outcomes</source>
            <year>2024</year>
            <month>Aug</month>
            <volume>8</volume>
            <issue>4</issue>
            <fpage>396</fpage>
            <page-range>396-405</page-range>
            <pub-id pub-id-type="pmid">39100655</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Drissa</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Helali</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chebbi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ezzaouia</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Omri</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Drissa</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Prosthetic valve endocarditis: clinical, bacteriological and therapeutic aspects.</article-title>
            <source>Tunis Med</source>
            <year>2017</year>
            <month>Jul</month>
            <volume>95</volume>
            <issue>7</issue>
            <fpage>461</fpage>
            <page-range>461-465</page-range>
            <pub-id pub-id-type="pmid">29694648</pub-id>
          </element-citation>
        </ref>
        <ref id="article-18876.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Delgado</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Ajmone Marsan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>de Waha</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bonaros</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Brida</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Burri</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Caselli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Doenst</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Ederhy</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Erba</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Foldager</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Fosb&#x000f8;l</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Kovac</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mestres</surname>
                <given-names>CA</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>OI</given-names>
              </name>
              <name>
                <surname>Miro</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Pazdernik</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Pizzi</surname>
                <given-names>MN</given-names>
              </name>
              <name>
                <surname>Quintana</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Risti&#x00107;</surname>
                <given-names>AD</given-names>
              </name>
              <name>
                <surname>Rod&#x000e9;s-Cabau</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Sionis</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Z&#x000fc;hlke</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Borger</surname>
                <given-names>MA</given-names>
              </name>
              <collab>ESC Scientific Document Group</collab>
            </person-group>
            <article-title>2023 ESC Guidelines for the management of endocarditis.</article-title>
            <source>Eur Heart J</source>
            <year>2023</year>
            <month>Oct</month>
            <day>14</day>
            <volume>44</volume>
            <issue>39</issue>
            <fpage>3948</fpage>
            <page-range>3948-4042</page-range>
            <pub-id pub-id-type="pmid">37622656</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
